Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism.
Amino Acid Sequence
Binding Sites
Cell Membrane
/ chemistry
Drug Discovery
Kinetics
Ligands
Lipid Bilayers
/ chemistry
Microscopy, Atomic Force
Molecular Docking Simulation
Molecular Dynamics Simulation
Peptides, Cyclic
/ chemistry
Protein Binding
Receptor, Anaphylatoxin C5a
/ chemistry
Structure-Activity Relationship
Thermodynamics
Journal
Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179
Informations de publication
Date de publication:
18 12 2020
18 12 2020
Historique:
received:
27
08
2020
accepted:
20
11
2020
entrez:
19
12
2020
pubmed:
20
12
2020
medline:
22
6
2021
Statut:
epublish
Résumé
A current challenge to produce effective therapeutics is to accurately determine the location of the ligand-biding site and to characterize its properties. So far, the mechanisms underlying the functional activation of cell surface receptors by ligands with a complex binding mechanism remain poorly understood due to a lack of suitable nanoscopic methods to study them in their native environment. Here, we elucidated the ligand-binding mechanism of the human G protein-coupled C5a receptor (C5aR). We discovered for the first time a cooperativity between the two orthosteric binding sites. We found that the N-terminus C5aR serves as a kinetic trap, while the transmembrane domain acts as the functional site and both contributes to the overall high-affinity interaction. In particular, Asp282 plays a key role in ligand binding thermodynamics, as revealed by atomic force microscopy and steered molecular dynamics simulation. Our findings provide a new structural basis for the functional and mechanistic understanding of the GPCR family that binds large macromolecular ligands.
Identifiants
pubmed: 33339958
doi: 10.1038/s42003-020-01518-8
pii: 10.1038/s42003-020-01518-8
pmc: PMC7749166
doi:
Substances chimiques
AcPhe(ornithine-Pro-cyclohexylamine-Trp-Arg)
0
Ligands
0
Lipid Bilayers
0
Peptides, Cyclic
0
Receptor, Anaphylatoxin C5a
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
786Subventions
Organisme : NIGMS NIH HHS
ID : R35 GM128641
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Nanoscale Horiz. 2018 May 1;3(3):293-304
pubmed: 32254077
J Phys Chem B. 2010 Feb 4;114(4):1652-60
pubmed: 20055378
Bioconjug Chem. 2011 Jun 15;22(6):1239-48
pubmed: 21542606
Inflammation. 2001 Jun;25(3):171-7
pubmed: 11403208
Chem Rev. 2017 Jan 11;117(1):139-155
pubmed: 27622975
PLoS One. 2016 Oct 21;11(10):e0164646
pubmed: 27768695
Curr Top Med Chem. 2015;15(24):2484-503
pubmed: 26126906
Pharmacol Rev. 2013 Jan;65(1):500-43
pubmed: 23383423
Protein Expr Purif. 2008 Dec;62(2):160-70
pubmed: 18782620
Nat Rev Immunol. 2004 Feb;4(2):133-42
pubmed: 15040586
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
Sci Rep. 2016 Apr 20;6:24575
pubmed: 27094554
Mol Immunol. 2011 Aug;48(14):1631-42
pubmed: 21549429
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4046-50
pubmed: 16593049
J Biol Chem. 2007 Feb 9;282(6):3664-71
pubmed: 17158873
J Biol Chem. 2019 Jun 14;294(24):9416-9429
pubmed: 31036565
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13573-8
pubmed: 22869712
Biophys J. 1997 Apr;72(4):1541-55
pubmed: 9083660
Nature. 2018 Jan 3;553(7686):111-114
pubmed: 29300009
J Exp Med. 2001 May 7;193(9):1059-66
pubmed: 11342590
J Immunol. 2003 Jun 15;170(12):6115-24
pubmed: 12794141
Br J Pharmacol. 2007 Oct;152(4):429-48
pubmed: 17603557
Annu Rev Immunol. 2005;23:821-52
pubmed: 15771587
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1214-8
pubmed: 8108389
Nat Commun. 2015 Nov 12;6:8857
pubmed: 26561004
EMBO J. 1997 Dec 1;16(23):6996-7007
pubmed: 9384579
Trends Biochem Sci. 2020 Aug;45(8):693-705
pubmed: 32402749
Biophys J. 2006 Jun 15;90(12):4686-91
pubmed: 16581843
J Biol Chem. 2019 Mar 8;294(10):3464-3475
pubmed: 30567735
Chem Commun (Camb). 2018 Jun 19;54(50):6903-6906
pubmed: 29808215
Nat Rev Drug Discov. 2019 Jan;18(1):59-82
pubmed: 30410121
Nat Methods. 2013 Sep;10(9):847-54
pubmed: 23985731
J Am Soc Nephrol. 2017 Sep;28(9):2756-2767
pubmed: 28400446
ACS Nano. 2015 Jun 23;9(6):5846-56
pubmed: 26013956
J Chem Theory Comput. 2018 May 8;14(5):2761-2770
pubmed: 29660291
J Endocrinol. 2008 Mar;196(3):435-53
pubmed: 18310440
Mol Cell. 2008 Jun 20;30(6):667-77
pubmed: 18570870
Nat Struct Mol Biol. 2018 Jun;25(6):472-481
pubmed: 29867214
Mol Pharmacol. 2004 Apr;65(4):868-79
pubmed: 15044616
Nat Methods. 2015 Sep;12(9):845-851
pubmed: 26167642